Images

<p class="p1"><b>Retatrutide (LY-3437943) — Triple-Agonist Research Peptide</b></p> <p class="p3">Push metabolic-disease investigation forward with Retatrutide, the once-weekly synthetic peptide that co-activates GLP-1, GIP and glucagon receptors. In Phase 2 studies, participants lost up to <span class="s1"><b>24 % of body weight after 48 weeks</b></span>, positioning Retatrutide at the forefront of next-generation obesity and T2D therapeutics.</p> <ul> <li> <p class="p1"><span class="s1"><b>Purity:</b></span> &gt; 99 % (HPLC)</p> </li> <li> <p class="p1"><b>Molecular Weight:</b><span class="s1"> ≈ 4.8 kDa</span></p> </li> <li> <p class="p1"><span class="s1"><b>Form &amp; Sizes:</b></span> Lyophilized powder in <span class="s1"><b>10 mg</b></span> and <span class="s1"><b>30 mg</b></span> research-grade vials</p> </li> <li> <p class="p1"><span class="s1"><b>Solubility:</b></span> Sterile water or 0.6 % saline</p> </li> <li> <p class="p1"><span class="s1"><b>Storage:</b></span> −20 °C long-term; aliquoted reconstitutions ≤ −80 °C</p> </li> </ul> <p><i>For laboratory research use only. Not for human administration.</i><i></i></p>

Research supply

Retatrutide

Product information

30mg

$249.00

Product options

10mg
--
30mg
$249.00
Qty

COA available

Certificates of Analysis for this batch

View the Certificate of Analysis for the in-stock lot(s) below.

Have a lot number? Look up your COA.

Product notes

Retatrutide (LY-3437943) — Triple-Agonist Research Peptide

Push metabolic-disease investigation forward with Retatrutide, the once-weekly synthetic peptide that co-activates GLP-1, GIP and glucagon receptors. In Phase 2 studies, participants lost up to 24 % of body weight after 48 weeks, positioning Retatrutide at the forefront of next-generation obesity and T2D therapeutics.

  • Purity: > 99 % (HPLC)

  • Molecular Weight: ≈ 4.8 kDa

  • Form & Sizes: Lyophilized powder in 10 mg and 30 mg research-grade vials

  • Solubility: Sterile water or 0.6 % saline

  • Storage: −20 °C long-term; aliquoted reconstitutions ≤ −80 °C

For laboratory research use only. Not for human administration.

You may also like